NASDAQ : LXRX
Lexicon Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.48 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 658.53M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Lexicon Pharmaceuticals, Inc. (LXRX) reported revenue of 41.47M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 41.47M | 49.80M | 31.08M | 1.20M | 139.00K | 298.00K |
| Cost of Revenue | 5.80M | 6.56M | 6.46M | 5.22M | 52.52M | 55.05M |
| Gross Profit | 35.67M | 43.24M | 24.63M | -4.02M | -52.38M | -54.75M |
| Selling, General & Admin | 35.34M | 37.32M | 143.10M | 113.98M | 48.08M | 32.34M |
| Research & Development | 54.83M | 54.83M | 77.54M | 53.75M | ||
| Operating Expenses | 90.18M | 92.15M | 220.64M | 167.73M | 48.08M | 32.34M |
| Operating Income | -54.50M | -48.91M | -196.02M | -171.75M | -100.46M | -87.09M |
| Interest Expense | -8.38M | -8.34M | -15.58M | -13.10M | -2.78M | -802.00K |
| Interest & Investment Income | 6.12M | 6.91M | 12.29M | 7.73M | 1.60M | 134.00K |
| EBT Excluding Unusual Items | -56.77M | -50.34M | -199.30M | -177.12M | -101.64M | -87.76M |
| Other Unusual Items | -4.35M | -1.10M | -300.00K | |||
| Pretax Income | -61.12M | -50.34M | -200.40M | -177.12M | -101.94M | -87.76M |
| Net Income | -61.12M | -50.34M | -200.40M | -177.12M | -101.94M | -87.76M |
| Net Income to Common | -61.12M | -50.34M | -200.40M | -177.12M | -101.94M | -87.76M |
| Shares Outstanding (Basic) | 391.23M | 363.05M | 320.03M | 221.13M | 165.73M | 145.65M |
| Shares Outstanding (Diluted) | 391.23M | 363.05M | 320.03M | 221.13M | 165.73M | 145.65M |
| EPS (Basic) | -0.16 | -0.14 | -0.63 | -0.80 | -0.62 | -0.60 |
| EPS (Diluted) | -0.16 | -0.14 | -0.63 | -0.80 | -0.62 | -0.60 |
| Free Cash Flow | -64.99M | -67.85M | -179.81M | -162.37M | -90.18M | -88.24M |
| Free Cash Flow Per Share | -0.17 | -0.19 | -0.56 | -0.73 | -0.54 | -0.61 |
| Gross Margin | 86.02% | 86.82% | 79.23% | |||
| Operating Margin | -131.43% | -98.21% | -630.67% | -14,264.95% | -72,273.38% | -29,224.83% |
| Profit Margin | -147.38% | -101.08% | -644.78% | -14,710.88% | -73,341.01% | -29,448.99% |
| Free Cash Flow Margin | -156.72% | -136.24% | -578.52% | -13,485.63% | -64,875.54% | -29,610.07% |
| EBITDA | -54.02M | -48.29M | -195.48M | -171.20M | -100.03M | -86.80M |
| EBITDA Margin | -130.27% | -96.96% | ||||
| D&A For EBITDA | 481.00K | 621.00K | 534.00K | 554.00K | 427.00K | 292.00K |
| EBIT | -54.50M | -48.91M | -196.02M | -171.75M | -100.46M | -87.09M |
| EBIT Margin | -131.43% | -98.21% | ||||
| Revenue as Reported | 41.47M | 49.80M | 31.08M | 1.20M | 139.00K | 298.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 40.92M | 34.33M | 66.66M | 22.46M | 46.34M | 64.06M |
| Short-Term Investments | 149.69M | 61.90M | 171.30M | 147.56M | 92.01M | 22.68M |
| Cash & Short-Term Investments | 190.61M | 96.23M | 237.96M | 170.03M | 138.36M | 86.74M |
| Receivables | 1.64M | 2.38M | 3.47M | 1.01M | 28.00K | 14.00K |
| Inventory | 1.20M | 281.00K | 231.00K | 381.00K | ||
| Prepaid Expenses | 3.13M | 3.00M | 4.53M | 5.13M | 2.48M | 2.16M |
| Total Current Assets | 196.58M | 101.89M | 246.19M | 176.55M | 140.87M | 88.92M |
| Property, Plant & Equipment | 8.57M | 9.18M | 7.32M | 7.51M | 8.48M | 3.44M |
| Goodwill | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M |
| Other Long-Term Assets | 368.00K | 29.37M | 368.00K | 828.00K | 412.00K | |
| Total Assets | 250.06M | 184.99M | 298.42M | 229.43M | 194.30M | 136.91M |
| Accounts Payable | 2.34M | 3.08M | 14.80M | 14.39M | 10.39M | 9.15M |
| Accrued Expenses | 10.72M | 11.55M | 29.27M | 15.87M | 11.49M | 11.88M |
| Current Portion of Long-Term Debt | 4.59M | |||||
| Current Portion of Leases | 1.64M | 1.64M | 1.18M | 1.29M | 1.29M | 1.09M |
| Total Current Liabilities | 14.71M | 20.87M | 45.25M | 31.55M | 23.17M | 22.12M |
| Long-Term Debt | 51.44M | 49.41M | 100.30M | 99.51M | 48.58M | |
| Long-Term Leases | 6.16M | 6.59M | 4.60M | 5.26M | 5.42M | 1.19M |
| Other Long-Term Liabilities | 3.23M | 582.00K | 2.32M | |||
| Total Liabilities | 75.53M | 77.45M | 152.47M | 136.32M | 77.17M | 23.31M |
| Common Stock | 447.00K | 366.00K | 363.00K | 245.00K | 189.00K | 150.00K |
| Additional Paid-In Capital | 2.23B | 2.13B | 2.12B | 1.86B | 1.71B | 1.61B |
| Retained Earnings | -2.05B | -2.02B | -1.97B | -1.77B | -1.59B | -1.49B |
| Treasury Stock | -2.84M | -5.19M | -4.62M | -2.88M | -2.06M | -7.52M |
| Comprehensive Income & Other | -204.00K | 30.00K | 119.00K | 31.00K | -428.00K | -10.00K |
| Shareholders' Equity | 174.53M | 107.54M | 145.95M | 93.11M | 117.12M | 113.59M |
| Total Liabilities & Equity | 250.06M | 184.99M | 298.42M | 229.43M | 194.30M | 136.91M |
| Total Debt | 59.24M | 62.24M | 106.07M | 106.06M | 55.29M | 2.28M |
| Net Cash (Debt) | 131.37M | 33.99M | 131.88M | 63.96M | 83.06M | 84.46M |
| Net Cash Per Share | 0.34 | 0.09 | 0.41 | 0.29 | 0.50 | 0.58 |
| Filing Date Shares Outstanding | 444.96M | 423.68M | 361.49M | 246.24M | 188.73M | 149.59M |
| Total Common Shares Outstanding | 444.94M | 363.47M | 361.49M | 244.92M | 188.73M | 148.92M |
| Working Capital | 181.87M | 81.03M | 200.94M | 145.00M | 117.69M | 66.80M |
| Book Value Per Share | 0.39 | 0.30 | 0.40 | 0.38 | 0.62 | 0.76 |
| Tangible Book Value | 129.98M | 62.99M | 101.41M | 48.57M | 72.58M | 69.05M |
| Tangible Book Value Per Share | 0.29 | 0.17 | 0.28 | 0.20 | 0.38 | 0.46 |
| Machinery | 2.39M | 2.39M | 2.39M | 4.35M | 4.00M | 4.72M |
| Leasehold Improvements | 2.18M | 2.18M | 2.18M | 2.18M | 2.05M | 1.31M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -61.12M | -50.34M | -200.40M | -177.12M | -101.94M | -87.76M |
| Depreciation & Amortization | 481.00K | 621.00K | 534.00K | 554.00K | 427.00K | 292.00K |
| Other Amortization | 2.11M | 1.70M | 1.84M | 1.77M | 741.00K | 54.00K |
| Loss (Gain) From Sale of Assets | 3.00K | 49.00K | ||||
| Loss (Gain) From Sale of Investments | -2.46M | -3.71M | -9.30M | -5.62M | ||
| Stock-Based Compensation | 12.69M | 12.52M | 13.50M | 14.34M | 11.52M | 10.58M |
| Other Operating Activities | 4.07M | -1.74M | 812.00K | 1.51M | ||
| Change in Accounts Receivable | 540.00K | 1.09M | -2.46M | -982.00K | -14.00K | 381.00K |
| Change in Inventory | -1.03M | -50.00K | 150.00K | -381.00K | ||
| Change in Accounts Payable | -21.65M | -30.22M | 14.80M | 6.45M | 76.00K | -14.16M |
| Change in Other Net Operating Assets | 1.38M | 2.29M | 1.75M | -2.43M | 340.00K | 3.55M |
| Operating Cash Flow | -64.99M | -67.85M | -178.78M | -161.90M | -88.85M | -87.02M |
| Capital Expenditures | -1.03M | -470.00K | -1.33M | -1.22M | ||
| Investment in Securities | -29.77M | 113.02M | -14.35M | -49.47M | -69.75M | 3.33M |
| Investing Cash Flow | -29.77M | 113.02M | -15.38M | -49.94M | -71.08M | 2.11M |
| Long-Term Debt Issued | 49.96M | 48.87M | ||||
| Long-Term Debt Repaid | -48.00M | -11.70M | ||||
| Net Debt Issued (Repaid) | -7.26M | -48.00M | 49.96M | 48.87M | -11.70M | |
| Issuance of Common Stock | 71.15M | 73.00K | 64.00K | 138.82M | 94.20M | 37.08M |
| Repurchase of Common Stock | -2.84M | -572.00K | -1.73M | -824.00K | -864.00K | -2.67M |
| Other Financing Activities | -2.27M | -1.31M | ||||
| Financing Cash Flow | 85.32M | -48.50M | 238.35M | 187.96M | 142.21M | 22.71M |
| Net Cash Flow | -9.44M | -3.33M | 44.19M | -23.88M | -17.72M | -62.20M |
| Free Cash Flow | -64.99M | -67.85M | -179.81M | -162.37M | -90.18M | -88.24M |
| Free Cash Flow Margin | -156.72% | -136.24% | -578.52% | -13,485.63% | -64,875.54% | -29,610.07% |
| Free Cash Flow Per Share | -0.17 | -0.19 | -0.56 | -0.73 | -0.54 | -0.61 |
| Levered Free Cash Flow | -44.77M | -47.82M | -105.30M | -94.97M | -52.65M | -55.54M |
| Unlevered Free Cash Flow | -41.64M | -44.30M | -97.41M | -88.56M | -51.65M | -55.09M |
| Cash Interest Paid | 6.05M | 8.33M | 12.92M | 10.06M | 2.29M | 799.00K |
| Change in Working Capital | -20.76M | -26.89M | 14.24M | 2.66M | 402.00K | -10.23M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 631.84M | 417.91M | 266.96M | 373.36M | 360.47M | 586.65M |
| Enterprise Value | 500.47M | 366.91M | 114.47M | 260.93M | 254.89M | 479.93M |
| Last Close Price | 1.42 | 1.15 | 0.74 | 1.53 | 1.91 | 3.94 |
| Forward PE | 25.17 | 25.17 | 25.17 | 25.17 | 25.17 | |
| PS Ratio | 15.24 | 8.39 | 8.59 | 310.10 | 2,593.28 | 1,968.62 |
| PB Ratio | 3.62 | 3.89 | 1.83 | 4.01 | 3.08 | 5.16 |
| P/TBV Ratio | 4.86 | 6.63 | 2.63 | 7.69 | 4.97 | 8.50 |
| EV/Sales Ratio | 12.07 | 7.37 | 3.68 | 216.72 | 1,833.75 | 1,610.51 |
| Debt / Equity Ratio | 0.34 | 0.58 | 0.73 | 1.14 | 0.47 | 0.02 |
| Net Debt / Equity Ratio | -0.75 | -0.32 | -0.90 | -0.69 | -0.71 | -0.74 |
| Net Debt / EBITDA Ratio | 2.43 | 0.70 | 0.68 | 0.37 | 0.83 | 0.97 |
| Net Debt / FCF Ratio | 2.02 | 0.50 | 0.73 | 0.39 | 0.92 | 0.96 |
| Asset Turnover | 0.17 | 0.21 | 0.12 | 0.01 | 0.00 | 0.00 |
| Inventory Turnover | 8.50 | 25.64 | 21.09 | |||
| Quick Ratio | 13.07 | 4.73 | 5.34 | 5.42 | 5.97 | 3.92 |
| Current Ratio | 13.37 | 4.88 | 5.44 | 5.60 | 6.08 | 4.02 |
| Return on Equity (ROE) | -40.21% | -39.72% | -167.66% | -168.50% | -88.37% | -65.01% |
| Return on Assets (ROA) | -14.32% | -12.65% | -46.42% | -50.67% | -37.91% | -31.95% |
| Return on Capital Employed (ROCE) | -23.20% | -29.80% | -77.40% | -86.80% | -58.70% | -75.90% |
| Earnings Yield | -11.18% | -12.05% | -75.07% | -47.44% | -28.28% | -14.96% |
| FCF Yield | -10.29% | -16.24% | -67.36% | -43.49% | -25.02% | -15.04% |
| Buyback Yield / Dilution | -7.98% | -13.44% | -44.73% | -33.42% | -13.79% | -31.41% |